To be unveiled at Interphex, new solutions empower companies to better control production and classified environments
Lyndhurst, NJ - Sika continues to expand its portfolio of high-performance flooring solutions with a service offering designed specifically to meet the wide-ranging needs of pharmaceutical manufacturers. Soon to be unveiled at Interphex (April 17-19; Javits Center, New York City), the service will enable life sciences companies to assert greater control over the design, construction, maintenance and cost of existing and new facilities.
Sika, the world’s largest manufacturer of pharmaceutical floor and wall systems, is making available to architects, designers and managers of pharmaceutical facilities its network of technical, design and construction experts to create systems that address the unique demands pharma environments. Working along with Sika’s installation partners—a carefully vetted group of professionals averaging 20 years of pharma construction experience, companies can benefit from time-and cost-saving installation technology, shaving weeks off construction and allowing pharmaceutical manufacturers to assert greater control over shutdown and production start dates.
In applications for cleanrooms and other areas requiring the most stringent environmental monitoring, Sika has developed a hygienic envelope system that integrates floors, walls and ceilings into a seamless, non-porous, chemical resistant barrier. This technique facilitates the ease and speed of sanitization and prevents liquids from compromising the substrate which could create the possibility of back side mold growth.
“Controlled spaces in biologics, pharmaceutical, medical device and clean production facilities are subject to both local and global inspections against rigorous standards,” said Jim Hendley, Life Sciences Vertical Market Manager, Sika Corporation USA. “At Sika, we believe it is essential to integrate the designer, manufacturer and facility manager in to a team, to understand these issues and provide a holistic, no-surprise, flooring and—importantly—full-envelope system that maintain performance expectations, sterility and construction schedules.”
This approach ensures the facility owner greater control over the performance of the system through its lifetime and prevents failures with solutions that offer superior design properties to meet the rigorous standards of a pharmaceutical manufacturing facility. Sika systems offer exceptional durability and longevity with high levels of resistance to chemical, mechanical and impact resistances so when facilities are inspected they not only are sanitary, they look sanitary. Additionally, Sika’s cleanroom systems release 1,000 times fewer emissions than standard low VOC systems.
The session will be held on Technical Conference Stage 5, Booth 1677 from 3:00pm to 3:30pm on April 17, 2018.
About Sika Corporation USA
Sika is a specialty chemicals company with a leading position in the development and production of systems and products for bonding, sealing, damping, reinforcing and protecting in the building sector and automotive industry. Sika has subsidiaries in 100 countries around the world and manufactures in over 190 factories. Its more than 17,000 employees generated annual sales of CHF 6.4 billion in 2017. For more information about Sika Corporation visit https://usa.sika.com/
SOURCE: Sika Corporation